Peter A Thompson Insider Trading $EWTX Edgewise Therapeutics, Inc.
Get free email notifications about insider trading for Peter A Thompson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).
Peter A Thompson in Edgewise Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 13,046,956 shares
Latest Transaction: Mar 31 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter A Thompson in Edgewise Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 272,724 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,668,350 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,301,626 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,572,960 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 8,187,100 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Buy | P | 16.00 | 312,500 | 5,000,000 | 13,359,456 | 13 M to 13.4 M (+2.40 %) |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Buy | P | 16.00 | 46,875 | 750,000 | 319,599 | 272.7 K to 319.6 K (+17.19 %) |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Buy | C | 0.00 | 272,724 | 0 | 272,724 | 0 to 272.7 K |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Buy | C | 0.00 | 12,730,036 | 0 | 13,046,956 | 316.9 K to 13 M (+4,016.80 %) |
Page: 1